Co-Founder @ Chymal Therapeutics (January 2025 - March 2026)
Co-Founder and Chief Scientific Officer @ (April 2022 - October 2025)
Co-Founder and Senior VP, Research @ (April 2016 - April 2022)
PhD Candidate in Systems Pharmacology and Translational Therapeutics @ (August 2013 - October 2018)
Doctor of Pharmacy (PharmD) @ (August 2007 - May 2013)
Student Researcher in Molecular Biology @ (September 2010 - September 2012)
Research Intern - Antibiotic Development @ (June 2010 - September 2010)
Michael Klichinsky Education
University of Pennsylvania
Doctor of Philosophy - PhD (Pharmacology)
2013-2018
University of the Sciences in Philadelphia
Doctor of Pharmacy (PharmD) (Pharmacy)
2007-2013
Michael Klichinsky Skills
Pharmacy
Molecular Biology
Strategy
Public Speaking
Raiser's Edge
Genetics
Reality TV
Biology
Management
SPSS
Michael Klichinsky Summary
Michael Klichinsky, based in Philadelphia, PA, US, is currently a Chief Scientific Officer at Nava Therapeutics. Michael Klichinsky brings experience from previous roles at Chymal Therapeutics, Carisma Therapeutics and University of Pennsylvania. Michael Klichinsky holds a 2013 - 2018 Doctor of Philosophy - PhD in Pharmacology @ University of Pennsylvania. With a robust skill set that includes Pharmacy, Molecular Biology, Strategy, Public Speaking, Raiser's Edge and more. Michael Klichinsky has 4 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michael Klichinsky?
Find contact details for 700 million professionals.